19#iSCLife®-LC

human umbilical cord-derived mesenchymal stem cells · Sclnow Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 19#iSCLife®-LC, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis [Phase 1]

See pricing